Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Vion begins phase I trial of intravenous TAPET at Royal Marsden Hospital

July 25, 2000

Licensing opportunity from Immunex: interleukin-15 (IL-15)

July 24, 2000

Yeda presents new agents for PDT of tumors

July 24, 2000

Combination therapy with G-3139 and dacarbazine as new approach to malignant melanoma

July 24, 2000

Titan acquires novel agent for the treatment of cancer and viral disease

July 24, 2000

Valtaxin approved in Canada for CIS of the bladder

July 24, 2000

NeoPharm seeks clearance to begin clinical development of LE-AON

July 21, 2000

SB presents new inhibitors of a cell cycle-regulating kinase

July 21, 2000

Selectin modulators and their use described in recent patent by Ontogen and Organon

July 21, 2000

Myocet successfully substitutes for doxorubicin in CHOP therapy of AIDS-related lymphomas

July 21, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...